Latest Breaking News On - Viracta therapeutic board - Page 1 : comparemela.com

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the succession.

United kingdomIvor roystonMark rotheraAshleigh barretoRogerj pomerantzCambridge universityHead of investor relations corporate communicationsAegerion pharmaceuticals incPrnewswire viracta therapeutics incNatural sciencesEuropean institute for business administrationViracta therapeutics incViracta therapeutic boardChief executiveChief executive officerViracta board